Noguchi C T, Ackerman S, DiMaio J, Schiller P W, Schechter A N
Mol Pharmacol. 1983 Jan;23(1):100-3.
Among the class of non-covalent inhibitors of deoxyhemoglobin S gelation, the aromatic amino acids have been shown to be the most effective. We have examined several synthetic chemical modifications of phenylalanine in order to determine the stereospecific constraints for inhibition of gelation by this class of compounds. The phenylalanine derivatives with ring modification by electron-donating groups (NH2, CH3, or OH) inhibited gelation to the same order of magnitude as phenylalanine (10-20% increase in deoxyhemoglobin S solubility at 32 mM). The phenylalanine derivative with the electron-withdrawing group NO2 in the p-position behaved similarly, but the inhibitory effect was eliminated by NO2 in the m- and possibly o-positions. Furthermore, side-chain modifications also eliminated the inhibitory effect. These studies, in conjunction with crystallographic analyses of the binding sites of gelation inhibitors, may provide a rational strategy for finding suitable compounds (whether covalent or non-covalent inhibitors) with appropriate physicochemical and biological properties to pursue as potential therapies with sickle cell disease.
在脱氧血红蛋白S凝胶化的非共价抑制剂类别中,芳香族氨基酸已被证明是最有效的。我们研究了苯丙氨酸的几种合成化学修饰,以确定这类化合物抑制凝胶化的立体特异性限制。通过供电子基团(NH2、CH3或OH)进行环修饰的苯丙氨酸衍生物抑制凝胶化的程度与苯丙氨酸相同(在32 mM时,脱氧血红蛋白S溶解度增加10 - 20%)。对位带有吸电子基团NO2的苯丙氨酸衍生物表现类似,但间位和可能的邻位的NO2会消除抑制作用。此外,侧链修饰也会消除抑制作用。这些研究,结合凝胶化抑制剂结合位点的晶体学分析,可能为寻找具有合适物理化学和生物学特性的合适化合物(无论是共价还是非共价抑制剂)提供合理策略,以作为镰状细胞病的潜在治疗方法。